FIELD: chemistry.
SUBSTANCE: invention refers to using L-alaninium acetyl salicylate of formula 1 as anticoagulant activity agent.
EFFECT: compound has anticoagulant activity comparable to heparin.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT EXHIBITING ANTIAGGREGATORY ACTIVITY | 2019 |
|
RU2727508C1 |
N'-PYRIDIN-4-YLMETHYLENE-2-[6-METHYL-4-(THIETAN-3-YLOXY)PYRIMIDIN-2-YLTHIO]ACETOHYDRAZIDE, HAVING ANTIAGGREGATION AND ANTICOAGULANT ACTIVITY | 2024 |
|
RU2825129C1 |
2-BROMO-1-(4-BROMOPHENYL)ETHYLIDENE-2-[6-METHYL-4-(THIETAN-3-YLOXY)PYRIMIDIN-2-YLTHIO]ACETOHYDRAZIDE, HAVING ANTICOAGULATION AND ANTIAGGREGATION ACTIVITY | 2024 |
|
RU2824993C1 |
CYCLOHEXYLAMMONIUM SALT OF [3-METHYL-1-N-PROPYL-7-(1-OXOTHIETANYL-3)XANTHINYL-8-THIO]ACETIC ACID EXHIBITING ANTITHROMBOTIC ACTIVITY | 2011 |
|
RU2459826C1 |
PRODUCT WITH ANTIAGGREGATION AND ANTICOAGULANT EFFECTS, AND METHOD OF ITS PREPARATION | 2023 |
|
RU2808110C1 |
PREPARATION OF ANTICOAGULANT ACTION AND METHOD FOR ITS OBTAINING | 2006 |
|
RU2302250C1 |
CONJUGATES: THERAPEUTIC COMPOUND-FATTY ACID | 1994 |
|
RU2137755C1 |
TRIAZOLE DERIVATIVES EXHIBITING ANTIAGGREGATORY ACTIVITY | 2021 |
|
RU2770405C1 |
DERIVATIVES OF 1-(3,5-DI-TERT-BUTYL-4-HYDROXYBENZYL)ISATIN HAVING ANTIAGGREGATORY ACTIVITY | 2023 |
|
RU2822271C1 |
AGENT WITH ANTIAGGREGATORY ACTIVITY AND METHOD FOR PRODUCTION THEREOF | 2021 |
|
RU2778686C1 |
Authors
Dates
2019-10-18—Published
2019-02-18—Filed